Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Klaribact vs Klaricid in Healthy Subjects
NCT05436769Phase 1Completed
- Sponsor
- University of Karachi
- Start
- Oct 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clarithromycin in bacterial infection (2 arms), sponsored by University of Karachi. Primary endpoints: Maximum Plasma Drug Concentration, Area Under the Curve from time 0 to last measurable concentration and 1 more. Started Oct 2012; status: completed.
02
Drugs
clarithromycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05436769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05436769.